Development and Validation of a PSN-AI Prediction Model

计划入组 50 人 · 首次发布于 2024 年 1 月 30 日

Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens

计划入组 102 人 · 首次发布于 2008 年 1 月 29 日

A PK-PD Study of PSN821 in Type 2 Diabetes Patients (T2DM)

计划入组 66 人 · 首次发布于 2011 年 6 月 30 日

PSN-821

PSN-491

PSN-602

Personalis

United States

PSF, PLLC.

United States

BSN medical GmbH

Luxembourg

XELOX Regimen Shows Promise in Adjuvant Treatment for Stage III Colon Cancer

NAIP Breaks Ground on State-of-the-Art Pharmaceutical Research Centre in Nigeria's Anambra State

Battery-Free Sacral Neuromodulation Device Shows 84% Success Rate in Treating Urinary Incontinence